Avenue Therapeutics Inc. buy krebskrebs
Start price
18.10.21
/
50%
€16.50
Target price
18.10.22
€30.00
Performance (%)
-76.27%
End price
19.10.22
€3.92
Summary
This prediction ended on 19.10.22 with a price of €3.92. Massive losses of -76.27% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Avenue Therapeutics Inc. | - | - | - |
iShares Core DAX® | -3.935% | -2.628% | 10.013% |
iShares Nasdaq 100 | -3.608% | -9.283% | 20.668% |
iShares Nikkei 225® | -4.513% | -6.951% | 5.241% |
iShares S&P 500 | -2.607% | -4.402% | 20.177% |
Comments by krebskrebs for this prediction
In the thread Avenue Therapeutics diskutieren
Buy mit Kursziel 2,0
In the thread Trading Avenue Therapeutics
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten